Targeted tumor therapy: turning the genome on its head

TriBiotica has combined molecular biology of cancer and proprietary chemistry to implement an innovative therapeutic approach to cancer treatment. Instead of developing immunological reagents (such as cells, antibodies or chimeric receptors) targeting antigens already present on tumor cells, the new...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal for immunotherapy of cancer 2013-11, Vol.1 (S1), p.P133-P133, Article P133
Hauptverfasser:	Lawler, Matthew M, Dunn, Ian S, Newton, Estelle E, Rose, Lenora B, Kurnick, James T
Format:	Artikel
Sprache:	eng
Schlagworte:	Antigens Cancer Cervical cancer Immunotherapy Peptides Poster Presentation Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!